International Psoriasis Council
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Commentary: Sex differences in immune responses that underlie COVID-19 disease outcomes
Errol Prens, MD, PhD
Erasmus University Medical Center
Rotterdam, Netherlands
IPC Councilor
PUBLICATION
Sex differences in immune responses that underlie COVID-19 disease outcomes. Takahashi T, Ellingson MK, Wong P, Israelow B, Lucas C, Klein J, Silva J, Mao T, Oh JE, Tokuyama M, Lu P, Venkataraman A, Park A, Liu F, Meir A, Sun J, Wang EY, Casanovas-Massana A, Wyllie AL, Vogels CBF, Earnest R, Lapidus S, Ott IM, Moore AJ; Yale IMPACT Research Team, Shaw A, Fournier JB, Odio CD, Farhadian S, Dela Cruz C, Grubaugh ND, Schulz WL, Ring AM, Ko AI, Omer SB, Iwasaki A. Nature. 2020 Dec;588(7837):315-320. doi: 10.1038/s41586-020-2700-3. Epub 2020 Aug 26. PMID: 32846427; PMCID: PMC7725931.
COMMENTARY
Because of the growing body of evidence indicating sex differences in the clinical outcomes of coronavirus disease 2019 (COVID-19) infection, the IMPACT Research Team from Yale University investigated sex differences in viral loads, SARS-CoV-2-specific antibody titers, plasma cytokines, as well as blood cell phenotyping in COVID-19 patients. They discovered essential differences in immune responses during the disease course of SARS-CoV-2 infection in male versus female patients. First, they found that the levels of important pro-inflammatory innate immune chemokines and cytokines such as IL-8, IL-18 (at baseline), and CCL5 (longitudinal analysis) were higher in male patients, which correlated with more elevated non-classical monocytes (at baseline) and more severe disease. Second, they observed a more robust T cell response among female patients than male patients at baseline. Collectively, their data suggest that vaccines and therapies to elevate T cell immune response to SARS-CoV-2 might be warranted for male patients. In contrast, female patients might benefit from therapies that dampen innate immune activation early during disease. The immune landscape in COVID-19 patients is considerably different between the sexes. They conclude that these differences may underlie heightened disease susceptibility in men.
The authors recognize an important limitation of their study: healthy healthcare workers who served as controls were not matched to patients based on age, BMI, or underlying risk factors. Despite their corrections for those confounders in their statistical analyses, residual confounding is not ruled out due to underlying risk factors not available for the healthcare workers’ controls. The limited sample size of this study is an explicit limitation.
Lilly Announces a New, Citrate-Free Formulation of Taltz® (ixekizumab)
Arcutis Announces FDA Approval for ZORYVE (Roflumilast) Cream 0.3% for Plaque Psoriasis in Individuals Age 12 and Older
Un Enfoque en Psoriasis: Un Reporte de el Congreso RADLA 2022
Also Read
Commentary: Prevalence and Factors Associated with Sleep Disturbance in Adult Patients with Psoriasis
Sleep disorders are frequently found in patients with psoriasis, but the specific factors have remained elusive and have never been studied comprehensively. Esteban Dauden-Tello shares his expert opinion on a study which outlines the prevalence and characteristics associated with this still enigmatic aspect of psoriasis.
PsoProtect Registry Data Update
PsoProtect, a global registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis, has updated their preliminary data and now includes the first 1,652 cases.
Commentary: Biomarkers of Disease Progression in Psoriasis: Current State-of-the-Art
In personalized care for patients, psoriasis biomarkers will be highly relevant. At present, various centers have investigated biomarkers and their clinical significance for psoriasis progression. Read commentary from Andrea Chiricozzi, MD, on three recent publications.
Subscribe to the IPC Newsletter